For decades, the molecular conversations between proteins and DNA — the fleeting contacts that decide a cell's fate — have slipped through the fingers of even the most sophisticated laboratory methods. A new technique called D&D-seq, published in Cell, transforms DNA itself into a living record of these interactions, capturing them at the resolution of a single cell. By chemically inscribing the moment a regulatory protein touches the genome, researchers can now read the regulatory biography of individual cells rather than the blurred average of millions — a shift that carries profound implica
D&D-seq Maps DNA-Protein Interactions in Single Cells Using Base Editing
Cobertura Relacionada
GPS tracking reveals a northern boobook owl flew nonstop 1,848km from Japan to the Philippines in 36 hours, challenging …
Genetic Literacy Project · Aug 25 CRISPR-edited tomatoes yield 6x more fruit in cold conditions, study findsResearchers used CRISPR gene-editing to create tomato varieties that produce fruit reliably in cold conditions, yielding…
Space · Aug 25 Astronauts Complete ISS Antenna Replacement in Second SpacewalkNASA astronaut Anil Menon and ESA's Sophie Adenot conduct a spacewalk to replace a failed communications antenna on the …
Mental Floss · Aug 25 Test Your Knowledge: 25 Trivia Questions Spanning History and General FactsMental Floss presents 25 trivia questions testing readers' knowledge of August 25 historical events, general August fact…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
Scientific advancement in genetic research has no direct geopolitical implications; this is a biotechnology methodology paper with potential future applications in medical research.
Lente Econômica
D&D-seq base-editing technology enables single-cell mapping of DNA-protein interactions, advancing precision diagnostics and drug development in biotechnology and pharmaceutical sectors.
Consumers may benefit from improved disease diagnostics and personalized medicine approaches, though impacts are indirect and long-term as this is foundational research enabling future clinical applications.
Potential regulatory frameworks needed for single-cell genomic analysis standards; FDA may develop guidance for diagnostic tools using this technology; increased R&D tax incentives likely to support biotech innovation in this space.